Alcobra Ltd. (ADHD) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. STZ
4. PENG
5. NVDA
6. SPY
7. MSFT
8. SKYD
9. LEVI
10. APLD

Go back to Alcobra Ltd. (ADHD) Tops Q4 EPS by 4c

Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update

February 17, 2016 8:00 AM EST

Conference Call & Webcast February 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time

TEL AVIV, Israel, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq: ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome (Fragile X), today announced financial results for the three and twelve months ended December 31, 2015, and provided a corporate update.

Fourth Quarter and Fiscal Year Ended December 31, 2015 Financial Results:

Total operating expenses in the... More